Furthermore, the possible mechanisms utilised by IL-34 in atherogenesis have been demonstrated via a linkage among IL-34, obesity, chronic inflammation, and insulin resistance, suggesting that IL-34 enhances atheroma via insulin resistance in obese patients (88). Here, IL34 is linked to obesity due to melanocortin 4 receptor deficiency.